David F Hoffmeister bought stock once, on May 30, 2024

David F. Hoffmeister is an individual corporate director who has served on the board of StepStone Group Inc. (STEP) as a director since September 2020.( He is an experienced finance and strategy executive, best known for his tenure as Senior Vice President and Chief Financial Officer of Life Technologies Corporation from 2008 until its acquisition by Thermo Fisher Scientific in 2014, and previously as Chief Financial Officer of Invitrogen Corporation from 2004 to 2008, where he helped manage the merger that created Life Technologies.( In May 2024, he reported acquiring 22,500 shares of StepStone Group Inc., reflecting his role as a recent trading insider in the company.(

Earlier in his career, Hoffmeister spent about 20 years at McKinsey & Company as a senior partner advising clients in the healthcare, private equity, and chemicals sectors, after holding finance roles at GTE Corp. and W.R. Grace & Co.( He currently serves on the boards of Celanese Corporation (since 2005), Glaukos Corporation (since 2014), ICU Medical, Inc. (since 2018), and on the boards of Kaiser Foundation Hospitals and Kaiser Foundation Health Plan, Inc.( Hoffmeister holds a B.S. from the University of Minnesota and an MBA from the University of Chicago Booth School of Business, underpinning a career focused on corporate finance, healthcare, and life sciences governance.(

Written by Perplexity from public sources.